Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chlorhexidine + alcohol is a topical antiseptic combination used primarily for skin disinfection prior to surgical procedures or injections. The formulation typically contains chlorhexidine gluconate (an antiseptic biguanide compound) and isopropyl alcohol. Chlorhexidine acts as a broad-spectrum antimicrobial agent by binding to negatively charged bacterial cell walls and disrupting membrane integrity at higher concentrations. Alcohol provides rapid bactericidal action through protein denaturation and membrane disruption. Together, the combination offers both immediate and persistent antimicrobial activity against a wide range of bacteria (gram-positive and gram-negative), yeasts, and some viruses[1][3][6][8]. This product is widely used in healthcare settings for preoperative skin preparation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chlorhexidine + alcohol.